Skip to main content
Top
Published in: Diabetologia 9/2013

01-09-2013 | Article

Fatty acids differentially regulate insulin resistance through endoplasm reticulum stress-mediated induction of tribbles homologue 3: a potential link between dietary fat composition and the pathophysiological outcomes of obesity

Authors: T. Geng, W. Hu, M. H. Broadwater, J. M. Snider, J. Bielawski, S. B. Russo, J. H. Schwacke, J. Ross, L. A. Cowart

Published in: Diabetologia | Issue 9/2013

Login to get access

Abstract

Aims/hypothesis

Previous studies have shown that saturated fatty acids cause insulin resistance (IR) that is prevented by unsaturated fatty acids. Tribbles homologue 3 (TRIB3) is a putative endogenous inhibitor of insulin signalling, but its role in insulin signalling is controversial. This study aimed to determine whether fatty acids regulate IR via TRIB3.

Methods

We treated HepG2 cells with saturated and unsaturated fatty acids and evaluated TRIB3 expression. We then tested whether regulation of TRIB3 occurred through endoplasmic reticulum (ER) stress, and whether modulating TRIB3 and ER stress marker genes was necessary and/or sufficient for regulation of insulin signalling. To test the in vivo significance of this mechanism, we fed mice obesogenic diets with different fatty acid profiles and assessed physiological variables of diabetes, ER stress markers and Trib3 expression in the liver.

Results

Our data show that fatty acids differentially regulate IR through ER stress-mediated induction of TRIB3. Intriguingly, a standard and widely used obesogenic diet high in unsaturated fats failed to induce ER stress, TRIB3 or IR. However, an alternative obesogenic diet with lower unsaturated fat recapitulated the cell studies by causing ER stress, TRIB3 induction and IR.

Conclusions/interpretation

This study revealed a novel mechanism linking dietary fat composition to IR. Given the emerging roles for ER stress in non-alcoholic liver disease, we conclude that dietary fat composition rather than total amount may mediate hepatic pathology associated with obesity.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ros E (2003) Dietary cis-monounsaturated fatty acids and metabolic control in type 2 diabetes. Am J Clin Nutr 78:617S–625SPubMed Ros E (2003) Dietary cis-monounsaturated fatty acids and metabolic control in type 2 diabetes. Am J Clin Nutr 78:617S–625SPubMed
2.
go back to reference Czernichow S, Thomas D, Bruckert E (2010) n-6 Fatty acids and cardiovascular health: a review of the evidence for dietary intake recommendations. Br J Nutr 104:788–796PubMedCrossRef Czernichow S, Thomas D, Bruckert E (2010) n-6 Fatty acids and cardiovascular health: a review of the evidence for dietary intake recommendations. Br J Nutr 104:788–796PubMedCrossRef
3.
go back to reference Henique C, Mansouri A, Fumey G et al (2010) Increased mitochondrial fatty acid oxidation is sufficient to protect skeletal muscle cells from palmitate-induced apoptosis. J Biol Chem 285:36818–36827PubMedCrossRef Henique C, Mansouri A, Fumey G et al (2010) Increased mitochondrial fatty acid oxidation is sufficient to protect skeletal muscle cells from palmitate-induced apoptosis. J Biol Chem 285:36818–36827PubMedCrossRef
4.
go back to reference Coll T, Eyre E, Rodriguez-Calvo R et al (2008) Oleate reverses palmitate-induced insulin resistance and inflammation in skeletal muscle cells. J Biol Chem 283:11107–11116PubMedCrossRef Coll T, Eyre E, Rodriguez-Calvo R et al (2008) Oleate reverses palmitate-induced insulin resistance and inflammation in skeletal muscle cells. J Biol Chem 283:11107–11116PubMedCrossRef
5.
go back to reference Hu W, Ross J, Geng T, Brice SE, Cowart LA (2011) Differential regulation of dihydroceramide desaturase by palmitate versus monounsaturated fatty acids: implications for insulin resistance. J Biol Chem 286:16596–16605PubMedCrossRef Hu W, Ross J, Geng T, Brice SE, Cowart LA (2011) Differential regulation of dihydroceramide desaturase by palmitate versus monounsaturated fatty acids: implications for insulin resistance. J Biol Chem 286:16596–16605PubMedCrossRef
6.
go back to reference Bezy O, Vernochet C, Gesta S, Farmer SR, Kahn CR (2007) TRB3 blocks adipocyte differentiation through the inhibition of C/EBPβ transcriptional activity. Mol Cell Biol 27:6818–6831PubMedCrossRef Bezy O, Vernochet C, Gesta S, Farmer SR, Kahn CR (2007) TRB3 blocks adipocyte differentiation through the inhibition of C/EBPβ transcriptional activity. Mol Cell Biol 27:6818–6831PubMedCrossRef
7.
go back to reference Qi L, Heredia JE, Altarejos JY et al (2006) TRB3 links the E3 ubiquitin ligase COP1 to lipid metabolism. Science 312:1763–1766PubMedCrossRef Qi L, Heredia JE, Altarejos JY et al (2006) TRB3 links the E3 ubiquitin ligase COP1 to lipid metabolism. Science 312:1763–1766PubMedCrossRef
8.
go back to reference Kato S, Du K (2007) TRB3 modulates C2C12 differentiation by interfering with Akt activation. Biochem Biophys Res Commun 353:933–938PubMedCrossRef Kato S, Du K (2007) TRB3 modulates C2C12 differentiation by interfering with Akt activation. Biochem Biophys Res Commun 353:933–938PubMedCrossRef
9.
go back to reference Prudente S, Baratta R, Andreozzi F et al (2010) TRIB3 R84 variant affects glucose homeostasis by altering the interplay between insulin sensitivity and secretion. Diabetologia 53:1354–1361PubMedCrossRef Prudente S, Baratta R, Andreozzi F et al (2010) TRIB3 R84 variant affects glucose homeostasis by altering the interplay between insulin sensitivity and secretion. Diabetologia 53:1354–1361PubMedCrossRef
10.
go back to reference Jousse C, Deval C, Maurin AC et al (2007) TRB3 inhibits the transcriptional activation of stress-regulated genes by a negative feedback on the ATF4 pathway. J Biol Chem 282:15851–15861PubMedCrossRef Jousse C, Deval C, Maurin AC et al (2007) TRB3 inhibits the transcriptional activation of stress-regulated genes by a negative feedback on the ATF4 pathway. J Biol Chem 282:15851–15861PubMedCrossRef
11.
go back to reference Humphrey RK, Newcomb CJ, Yu SM et al (2010) Mixed lineage kinase-3 stabilizes and functionally cooperates with TRIBBLES-3 to compromise mitochondrial integrity in cytokine-induced death of pancreatic beta cells. J Biol Chem 285:22426–22436PubMedCrossRef Humphrey RK, Newcomb CJ, Yu SM et al (2010) Mixed lineage kinase-3 stabilizes and functionally cooperates with TRIBBLES-3 to compromise mitochondrial integrity in cytokine-induced death of pancreatic beta cells. J Biol Chem 285:22426–22436PubMedCrossRef
12.
go back to reference Du K, Herzig S, Kulkarni RN, Montminy M (2003) TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science 300:1574–1577PubMedCrossRef Du K, Herzig S, Kulkarni RN, Montminy M (2003) TRB3: a tribbles homolog that inhibits Akt/PKB activation by insulin in liver. Science 300:1574–1577PubMedCrossRef
13.
go back to reference Matsushima R, Harada N, Webster NJ, Tsutsumi YM, Nakaya Y (2006) Effect of TRB3 on insulin and nutrient-stimulated hepatic p70 S6 kinase activity. J Biol Chem 281:29719–29729PubMedCrossRef Matsushima R, Harada N, Webster NJ, Tsutsumi YM, Nakaya Y (2006) Effect of TRB3 on insulin and nutrient-stimulated hepatic p70 S6 kinase activity. J Biol Chem 281:29719–29729PubMedCrossRef
14.
go back to reference Prudente S, Sesti G, Pandolfi A, Andreozzi F, Consoli A, Trischitta V (2012) The mammalian tribbles homolog TRIB3, glucose homeostasis, and cardiovascular diseases. Endocr Rev 33:526–546PubMedCrossRef Prudente S, Sesti G, Pandolfi A, Andreozzi F, Consoli A, Trischitta V (2012) The mammalian tribbles homolog TRIB3, glucose homeostasis, and cardiovascular diseases. Endocr Rev 33:526–546PubMedCrossRef
15.
go back to reference Liu J, Wu X, Franklin JL et al (2010) Mammalian Tribbles homolog 3 impairs insulin action in skeletal muscle: role in glucose-induced insulin resistance. Am J Physiol Endocrinol Metab 298:E565–E576PubMedCrossRef Liu J, Wu X, Franklin JL et al (2010) Mammalian Tribbles homolog 3 impairs insulin action in skeletal muscle: role in glucose-induced insulin resistance. Am J Physiol Endocrinol Metab 298:E565–E576PubMedCrossRef
16.
go back to reference Koh HJ, Arnolds DE, Fujii N et al (2006) Skeletal muscle-selective knockout of LKB1 increases insulin sensitivity, improves glucose homeostasis, and decreases TRB3. Mol Cell Biol 26:8217–8227PubMedCrossRef Koh HJ, Arnolds DE, Fujii N et al (2006) Skeletal muscle-selective knockout of LKB1 increases insulin sensitivity, improves glucose homeostasis, and decreases TRB3. Mol Cell Biol 26:8217–8227PubMedCrossRef
17.
go back to reference Bi XP, Tan HW, Xing SS et al (2008) Overexpression of TRB3 gene in adipose tissue of rats with high fructose-induced metabolic syndrome. Endocr J 55:747–752PubMedCrossRef Bi XP, Tan HW, Xing SS et al (2008) Overexpression of TRB3 gene in adipose tissue of rats with high fructose-induced metabolic syndrome. Endocr J 55:747–752PubMedCrossRef
18.
go back to reference Prudente S, Scarpelli D, Chandalia M et al (2009) The TRIB3 Q84R polymorphism and risk of early-onset type 2 diabetes. J Clin Endocrinol Metab 94:190–196PubMedCrossRef Prudente S, Scarpelli D, Chandalia M et al (2009) The TRIB3 Q84R polymorphism and risk of early-onset type 2 diabetes. J Clin Endocrinol Metab 94:190–196PubMedCrossRef
19.
go back to reference Prudente S, Hribal ML, Flex E et al (2005) The functional Q84R polymorphism of mammalian Tribbles homolog TRB3 is associated with insulin resistance and related cardiovascular risk in Caucasians from Italy. Diabetes 54:2807–2811PubMedCrossRef Prudente S, Hribal ML, Flex E et al (2005) The functional Q84R polymorphism of mammalian Tribbles homolog TRB3 is associated with insulin resistance and related cardiovascular risk in Caucasians from Italy. Diabetes 54:2807–2811PubMedCrossRef
20.
go back to reference Oberkofler H, Pfeifenberger A, Soyal S et al (2010) Aberrant hepatic TRIB3 gene expression in insulin-resistant obese humans. Diabetologia 53:1971–1975PubMedCrossRef Oberkofler H, Pfeifenberger A, Soyal S et al (2010) Aberrant hepatic TRIB3 gene expression in insulin-resistant obese humans. Diabetologia 53:1971–1975PubMedCrossRef
21.
go back to reference Okamoto H, Latres E, Liu R et al (2007) Genetic deletion of Trb3, the mammalian Drosophila tribbles homolog, displays normal hepatic insulin signaling and glucose homeostasis. Diabetes 56:1350–1356PubMedCrossRef Okamoto H, Latres E, Liu R et al (2007) Genetic deletion of Trb3, the mammalian Drosophila tribbles homolog, displays normal hepatic insulin signaling and glucose homeostasis. Diabetes 56:1350–1356PubMedCrossRef
22.
go back to reference Iynedjian PB (2005) Lack of evidence for a role of TRB3/NIPK as an inhibitor of PKB-mediated insulin signalling in primary hepatocytes. Biochem J 386:113–118PubMedCrossRef Iynedjian PB (2005) Lack of evidence for a role of TRB3/NIPK as an inhibitor of PKB-mediated insulin signalling in primary hepatocytes. Biochem J 386:113–118PubMedCrossRef
23.
go back to reference Weismann D, Erion DM, Ignatova-Todorava I et al (2011) Knockdown of the gene encoding Drosophila tribbles homologue 3 (Trib3) improves insulin sensitivity through peroxisome proliferator-activated receptor-gamma (PPAR-γ) activation in a rat model of insulin resistance. Diabetologia 54:935–944PubMedCrossRef Weismann D, Erion DM, Ignatova-Todorava I et al (2011) Knockdown of the gene encoding Drosophila tribbles homologue 3 (Trib3) improves insulin sensitivity through peroxisome proliferator-activated receptor-gamma (PPAR-γ) activation in a rat model of insulin resistance. Diabetologia 54:935–944PubMedCrossRef
24.
go back to reference Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226:497–509PubMed Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226:497–509PubMed
25.
go back to reference Doss M, Oette K (1965) Rapid method for the preparation of fatty acid methyl esters for gas chromatographic analysis. Z Klin Chem Klin Biochem 3:125–129PubMed Doss M, Oette K (1965) Rapid method for the preparation of fatty acid methyl esters for gas chromatographic analysis. Z Klin Chem Klin Biochem 3:125–129PubMed
26.
go back to reference Seaborn GT, Katherine Moore M, Balazs GH (2005) Depot fatty acid composition in immature green turtles (Chelonia mydas) residing at two near-shore foraging areas in the Hawaiian Islands. Comp Biochem Physiol B Biochem Mol Biol 140:183–195PubMedCrossRef Seaborn GT, Katherine Moore M, Balazs GH (2005) Depot fatty acid composition in immature green turtles (Chelonia mydas) residing at two near-shore foraging areas in the Hawaiian Islands. Comp Biochem Physiol B Biochem Mol Biol 140:183–195PubMedCrossRef
27.
go back to reference Okada T, Furuhashi N, Kuromori Y, Miyashita M, Iwata F, Harada K (2005) Plasma palmitoleic acid content and obesity in children. Am J Clin Nutr 82:747–750PubMed Okada T, Furuhashi N, Kuromori Y, Miyashita M, Iwata F, Harada K (2005) Plasma palmitoleic acid content and obesity in children. Am J Clin Nutr 82:747–750PubMed
28.
go back to reference Nicoletti-Carvalho JE, Nogueira TC, Gorjao R et al (2010) UPR-mediated TRIB3 expression correlates with reduced AKT phosphorylation and inability of interleukin 6 to overcome palmitate-induced apoptosis in RINm5F cells. J Endocrinol 206:183–193PubMedCrossRef Nicoletti-Carvalho JE, Nogueira TC, Gorjao R et al (2010) UPR-mediated TRIB3 expression correlates with reduced AKT phosphorylation and inability of interleukin 6 to overcome palmitate-induced apoptosis in RINm5F cells. J Endocrinol 206:183–193PubMedCrossRef
29.
go back to reference Wei Y, Wang D, Topczewski F, Pagliassotti MJ (2006) Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. Am J Physiol Endocrinol Metab 291:E275–E281PubMedCrossRef Wei Y, Wang D, Topczewski F, Pagliassotti MJ (2006) Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. Am J Physiol Endocrinol Metab 291:E275–E281PubMedCrossRef
30.
go back to reference Ohoka N, Yoshii S, Hattori T, Onozaki K, Hayashi H (2005) TRB3, a novel ER stress-inducible gene, is induced via ATF4-CHOP pathway and is involved in cell death. EMBO J 24:1243–1255PubMedCrossRef Ohoka N, Yoshii S, Hattori T, Onozaki K, Hayashi H (2005) TRB3, a novel ER stress-inducible gene, is induced via ATF4-CHOP pathway and is involved in cell death. EMBO J 24:1243–1255PubMedCrossRef
31.
go back to reference Summers LK, Fielding BA, Bradshaw HA et al (2002) Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity. Diabetologia 45:369–377PubMedCrossRef Summers LK, Fielding BA, Bradshaw HA et al (2002) Substituting dietary saturated fat with polyunsaturated fat changes abdominal fat distribution and improves insulin sensitivity. Diabetologia 45:369–377PubMedCrossRef
32.
go back to reference Powell DJ, Hajduch E, Kular G, Hundal HS (2003) Ceramide disables 3-phosphoinositide binding to the pleckstrin homology domain of protein kinase B (PKB)/Akt by a PKCζ-dependent mechanism. Mol Cell Biol 23:7794–7808PubMedCrossRef Powell DJ, Hajduch E, Kular G, Hundal HS (2003) Ceramide disables 3-phosphoinositide binding to the pleckstrin homology domain of protein kinase B (PKB)/Akt by a PKCζ-dependent mechanism. Mol Cell Biol 23:7794–7808PubMedCrossRef
33.
go back to reference Zhang D, Christianson J, Liu ZX et al (2010) Resistance to high-fat diet-induced obesity and insulin resistance in mice with very long-chain acyl-CoA dehydrogenase deficiency. Cell Metab 11:402–411PubMedCrossRef Zhang D, Christianson J, Liu ZX et al (2010) Resistance to high-fat diet-induced obesity and insulin resistance in mice with very long-chain acyl-CoA dehydrogenase deficiency. Cell Metab 11:402–411PubMedCrossRef
34.
go back to reference Zhang D, Liu ZX, Choi CS et al (2007) Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance. Proc Natl Acad Sci U S A 104:17075–17080PubMedCrossRef Zhang D, Liu ZX, Choi CS et al (2007) Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance. Proc Natl Acad Sci U S A 104:17075–17080PubMedCrossRef
35.
go back to reference Holland WL, Brozinick JT, Wang LP et al (2007) Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 5:167–179PubMedCrossRef Holland WL, Brozinick JT, Wang LP et al (2007) Inhibition of ceramide synthesis ameliorates glucocorticoid-, saturated-fat-, and obesity-induced insulin resistance. Cell Metab 5:167–179PubMedCrossRef
36.
go back to reference Montell E, Turini M, Marotta M et al (2001) DAG accumulation from saturated fatty acids desensitizes insulin stimulation of glucose uptake in muscle cells. Am J Physiol Endocrinol Metab 280:E229–E237PubMed Montell E, Turini M, Marotta M et al (2001) DAG accumulation from saturated fatty acids desensitizes insulin stimulation of glucose uptake in muscle cells. Am J Physiol Endocrinol Metab 280:E229–E237PubMed
37.
go back to reference Bluher M (2010) The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr Opin Lipidol 21:38–43PubMedCrossRef Bluher M (2010) The distinction of metabolically 'healthy' from 'unhealthy' obese individuals. Curr Opin Lipidol 21:38–43PubMedCrossRef
38.
go back to reference Aguilar-Salinas CA, Garcia EG, Robles L et al (2008) High adiponectin concentrations are associated with the metabolically healthy obese phenotype. J Clin Endocrinol Metab 93:4075–4079PubMedCrossRef Aguilar-Salinas CA, Garcia EG, Robles L et al (2008) High adiponectin concentrations are associated with the metabolically healthy obese phenotype. J Clin Endocrinol Metab 93:4075–4079PubMedCrossRef
39.
go back to reference Hamer M, Stamatakis E (2012) Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab 97:2482–2488PubMedCrossRef Hamer M, Stamatakis E (2012) Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality. J Clin Endocrinol Metab 97:2482–2488PubMedCrossRef
40.
go back to reference Hankinson AL, Daviglus ML, van Horn L et al (2013) Diet composition and activity level of at risk and metabolically healthy obese American adults. Obesity (Silver Spring) 21:637–643CrossRef Hankinson AL, Daviglus ML, van Horn L et al (2013) Diet composition and activity level of at risk and metabolically healthy obese American adults. Obesity (Silver Spring) 21:637–643CrossRef
41.
go back to reference Pajunen P, Kotronen A, Korpi-Hyovalti E et al (2011) Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey. BMC Publ Health 11:754CrossRef Pajunen P, Kotronen A, Korpi-Hyovalti E et al (2011) Metabolically healthy and unhealthy obesity phenotypes in the general population: the FIN-D2D Survey. BMC Publ Health 11:754CrossRef
42.
go back to reference Calori G, Lattuada G, Piemonti L et al (2011) Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care 34:210–215PubMedCrossRef Calori G, Lattuada G, Piemonti L et al (2011) Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study. Diabetes Care 34:210–215PubMedCrossRef
43.
go back to reference Wang F, Liu H, Blanton WP, Belkina A, Lebrasseur NK, Denis GV (2010) Brd2 disruption in mice causes severe obesity without Type 2 diabetes. Biochem J 425:71–83CrossRef Wang F, Liu H, Blanton WP, Belkina A, Lebrasseur NK, Denis GV (2010) Brd2 disruption in mice causes severe obesity without Type 2 diabetes. Biochem J 425:71–83CrossRef
44.
go back to reference Rhee EP, Cheng S, Larson MG et al (2011) Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest 121:1402–1411PubMedCrossRef Rhee EP, Cheng S, Larson MG et al (2011) Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest 121:1402–1411PubMedCrossRef
45.
go back to reference Park SW, Zhou Y, Lee J, Ozcan U (2010) Sarco(endo)plasmic reticulum Ca2+-ATPase 2b is a major regulator of endoplasmic reticulum stress and glucose homeostasis in obesity. Proc Natl Acad Sci USA 107:19320–19325PubMedCrossRef Park SW, Zhou Y, Lee J, Ozcan U (2010) Sarco(endo)plasmic reticulum Ca2+-ATPase 2b is a major regulator of endoplasmic reticulum stress and glucose homeostasis in obesity. Proc Natl Acad Sci USA 107:19320–19325PubMedCrossRef
46.
go back to reference Fu S, Yang L, Li P et al (2011) Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity. Nature 473:528–531PubMedCrossRef Fu S, Yang L, Li P et al (2011) Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity. Nature 473:528–531PubMedCrossRef
47.
go back to reference Hotamisligil GS (2010) Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140:900–917PubMedCrossRef Hotamisligil GS (2010) Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140:900–917PubMedCrossRef
48.
Metadata
Title
Fatty acids differentially regulate insulin resistance through endoplasm reticulum stress-mediated induction of tribbles homologue 3: a potential link between dietary fat composition and the pathophysiological outcomes of obesity
Authors
T. Geng
W. Hu
M. H. Broadwater
J. M. Snider
J. Bielawski
S. B. Russo
J. H. Schwacke
J. Ross
L. A. Cowart
Publication date
01-09-2013
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 9/2013
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-013-2973-2

Other articles of this Issue 9/2013

Diabetologia 9/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine